X4 Pharmaceuticals, Inc
XFOR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001501697
In the last 90 days, X4 Pharmaceuticals, Inc insiders filed 0 open-market purchases and 3 sales; 89 institutions reported holding it in 13F filings for Q2 2026, worth $463.0M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in X4 Pharmaceuticals, Inc as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 59
- +5 vs. Q4 2022
- Shares held
- 61.5M
- +841.1K (+1.4%) vs. Q4 2022
- Total value
- $53.6M
- −$6.58M (−10.9%) vs. Q4 2022
- New holders
- 13
- 16 more added
- Sold out
- 8
- 10 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting XFOR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 89 | $463.0M |
| Q1 2026 | 84 | $388.1M |
| Q4 2025 | 79 | $357.7M |
| Q3 2025 | 42 | $55.3M |
| Q2 2025 | 52 | $5.33M |
| Q1 2025 | 94 | $23.3M |
| Q4 2024 | 90 | $73.2M |
| Q3 2024 | 98 | $67.3M |
| Q2 2024 | 99 | $58.9M |
| Q1 2024 | 98 | $143.2M |
| Q4 2023 | 93 | $81.2M |
| Q3 2023 | 91 | $122.6M |
| Q2 2023 | 96 | $219.1M |
| Q1 2023 | 59 | $53.6M |
| Q4 2022 | 54 | $60.2M |
| Q3 2022 | 59 | $66.9M |
| Q2 2022 | 51 | $15.5M |
| Q1 2022 | 56 | $28.6M |
| Q4 2021 | 52 | $40.2M |
| Q3 2021 | 52 | $85.7M |
| Q2 2021 | 63 | $107.8M |
| Q1 2021 | 61 | $138.7M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding X4 Pharmaceuticals, Inc; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| CWM, LLC | 2 | $0 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 3 | $3 | 0.00% | +3 | New |
| BNP Paribas Arbitrage, SA | 7 | $6 | 0.00% | −2−22.2% | Reduced |
| Advisor Group Holdings, Inc. | 529 | $460 | 0.00% | −4,440−89.4% | Reduced |
| Wells Fargo & Company | 753 | $655 | 0.00% | +326+76.3% | Added |
| Tower Research Capital LLC (TRC) | 810 | $1.00K | 0.00% | −9,417−92.1% | Reduced |
| Clearstead Advisors, LLC | 2,100 | $1.83K | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 4,000 | $3.48K | 0.00% | 00.0% | Unchanged |
| Ronald Blue Trust, Inc. | 8,520 | $8.00K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 10,092 | $9.00K | 0.00% | −84,702−89.4% | Reduced |
| Total Clarity Wealth Management, Inc. | 11,000 | $9.57K | 0.01% | +11,000 | New |
| Veritable, L.P. | 12,637 | $11.0K | 0.00% | 00.0% | Unchanged |
| Mission Wealth Management, LP | 15,000 | $13.1K | 0.00% | +15,000 | New |
| LexAurum Advisors, LLC | 16,000 | $13.9K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 16,044 | $14.0K | 0.00% | −6,058−27.4% | Reduced |
| Citadel Advisors LLC | 17,961 | $15.6K | 0.00% | −926,892−98.1% | Reduced |
| Jane Street Group, LLC | 21,568 | $18.8K | 0.00% | +21,568 | New |
| Commonwealth Equity Services, LLC | 22,500 | $19.0K | 0.00% | 00.0% | Unchanged |
| Invesco Ltd. | 29,945 | $26.1K | 0.00% | +14,331+91.8% | Added |
| Group One Trading, L.P. | 30,308 | $26.4K | 0.00% | +10,128+50.2% | Added |
| The PNC Financial Services Group, Inc. | 30,350 | $26.4K | 0.00% | −707−2.3% | Reduced |
| Simplex Trading, LLC | 32,788 | $28.0K | 0.00% | +14,464+78.9% | Added |
| Bleichroeder LP | 35,730 | $31.1K | 0.01% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 36,078 | $31.4K | 0.00% | 00.0% | Unchanged |
| CIBC Private Wealth Group, LLC | 41,500 | $36.1K | 0.00% | +41,500 | New |
| Landscape Capital Management, L.L.C. | 42,252 | $36.8K | 0.01% | +42,252 | New |
| Charles Schwab Investment Management Inc | 42,386 | $36.9K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 59,309 | $51.6K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 76,205 | $66.3K | 0.00% | +148+0.2% | Added |
| Goldman Sachs Group Inc | 83,482 | $72.6K | 0.00% | +28,502+51.8% | Added |
| Stifel Financial Corp | 93,497 | $81.3K | 0.00% | +11,501+14.0% | Added |
| XTX Topco Ltd | 96,649 | $84.1K | 0.02% | +96,649 | New |
| UBS Group AG | 100,000 | $87.0K | 0.00% | +100,000 | New |
| Virtu Financial LLC | 113,489 | $99.0K | 0.01% | +113,489 | New |
| State Street Corp | 170,633 | $148.5K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 171,193 | $148.9K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 224,470 | $195.3K | 0.00% | +77,757+53.0% | Added |
| Susquehanna International Group, LLP | 282,547 | $245.8K | 0.00% | +282,547 | New |
| New Leaf Venture Partners, L.L.C. | 335,000 | $291.4K | 0.24% | 00.0% | Unchanged |
| BlackRock Inc. | 343,580 | $298.9K | 0.00% | +68,894+25.1% | Added |
| Ikarian Capital, LLC | 349,133 | $303.7K | 0.13% | 00.0% | Unchanged |
| Simplify Asset Management Inc. | 400,000 | $348.0K | 0.06% | +400,000 | New |
| JPMorgan Chase & Co | 626,047 | $545.0K | 0.00% | +506,449+423.5% | Added |
| Point72 Asset Management, L.P. | 650,000 | $565.5K | 0.00% | 00.0% | Unchanged |
| Scoggin Management LP | 484,796 | $567.0K | 0.83% | +484,796 | New |
| Ghost Tree Capital, LLC | 850,000 | $740.0K | 0.28% | −150,000−15.0% | Reduced |
| Lynwood Capital Management Inc. | 900,000 | $783.0K | 1.16% | −1,255,100−58.2% | Reduced |
| Schonfeld Strategic Advisors LLC | 1,037,000 | $902.2K | 0.01% | +141,700+15.8% | Added |
| Millennium Management LLC | 1,080,213 | $940.0K | 0.00% | −73,220−6.3% | Reduced |
| Geode Capital Management, LLC | 1,108,684 | $964.6K | 0.00% | +521,168+88.7% | Added |
| Cormorant Asset Management, LP | 1,628,980 | $1.42M | 0.09% | 00.0% | Unchanged |
| Parkman Healthcare Partners LLC | 2,797,147 | $2.43M | 0.53% | +421,590+17.7% | Added |
| Tri Locum Partners LP | 3,878,484 | $3.37M | 1.03% | +171,967+4.6% | Added |
| Vanguard Group Inc | 4,344,311 | $3.78M | 0.00% | +763,922+21.3% | Added |
| AXA S.A. | 4,396,468 | $3.82M | 0.01% | +34,827+0.8% | Added |
| Perceptive Advisors LLC | 4,545,454 | $3.95M | 0.12% | +4,545,454 | New |
| OrbiMed Advisors LLC | 5,817,726 | $5.06M | 0.10% | 00.0% | Unchanged |
| NEA Management Company, LLC | 11,736,793 | $10.2M | 0.71% | 00.0% | Unchanged |
| Bain Capital Life Sciences Investors, LLC | 12,202,510 | $10.6M | 1.33% | 00.0% | Unchanged |
| CVI Holdings, LLC | 0 | $0 | 0.00% | −2,381,923−100.0% | Sold out |
| Sio Capital Management, LLC | 0 | $0 | 0.00% | −1,825,963−100.0% | Sold out |
| BVF Inc | 0 | $0 | 0.00% | −1,347,650−100.0% | Sold out |
| PEAK6 Investments LLC | 0 | $0 | 0.00% | −20,200−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −12,200−100.0% | Sold out |
| High Net Worth Advisory Group LLC | 0 | $0 | 0.00% | −1,100−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −272−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |